Cargando…

Fahr Syndrome Secondary to Pseudohypoparathyroidism

Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Sharon W, Sharma, Sakshi, Iqbal, Qasim Z, Romo, Karina G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690847/
https://www.ncbi.nlm.nih.gov/pubmed/38045865
http://dx.doi.org/10.1210/jcemcr/luad147
_version_ 1785152609938571264
author Shu, Sharon W
Sharma, Sakshi
Iqbal, Qasim Z
Romo, Karina G
author_facet Shu, Sharon W
Sharma, Sakshi
Iqbal, Qasim Z
Romo, Karina G
author_sort Shu, Sharon W
collection PubMed
description Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome. She initially presented with headache and was hospitalized for hypertensive emergency and severe hypocalcemia. Examination, including the neurologic examination, was unrevealing aside from hypertension and central adiposity. Laboratory tests were consistent with PHP, showing hypocalcemia with elevated PTH, and negative for hyperaldosteronism. Management of hypocalcemia consisted of intravenous calcium infusion, oral calcium carbonate, oral vitamin D3, and oral calcitriol. Patients with severe hypocalcemia and elevated PTH who present with new neurological symptoms despite normal general neurologic examination may warrant consideration for brain imaging to evaluate for Fahr syndrome. Further investigations are necessary to determine the prevalence of Fahr syndrome and hypokalemia in patients with PHP, explore if these findings are significantly associated with PHP-1b subtype, and ultimately inform potential new screening pathways for these patients.
format Online
Article
Text
id pubmed-10690847
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106908472023-12-02 Fahr Syndrome Secondary to Pseudohypoparathyroidism Shu, Sharon W Sharma, Sakshi Iqbal, Qasim Z Romo, Karina G JCEM Case Rep Case Report Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome. She initially presented with headache and was hospitalized for hypertensive emergency and severe hypocalcemia. Examination, including the neurologic examination, was unrevealing aside from hypertension and central adiposity. Laboratory tests were consistent with PHP, showing hypocalcemia with elevated PTH, and negative for hyperaldosteronism. Management of hypocalcemia consisted of intravenous calcium infusion, oral calcium carbonate, oral vitamin D3, and oral calcitriol. Patients with severe hypocalcemia and elevated PTH who present with new neurological symptoms despite normal general neurologic examination may warrant consideration for brain imaging to evaluate for Fahr syndrome. Further investigations are necessary to determine the prevalence of Fahr syndrome and hypokalemia in patients with PHP, explore if these findings are significantly associated with PHP-1b subtype, and ultimately inform potential new screening pathways for these patients. Oxford University Press 2023-12-01 /pmc/articles/PMC10690847/ /pubmed/38045865 http://dx.doi.org/10.1210/jcemcr/luad147 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shu, Sharon W
Sharma, Sakshi
Iqbal, Qasim Z
Romo, Karina G
Fahr Syndrome Secondary to Pseudohypoparathyroidism
title Fahr Syndrome Secondary to Pseudohypoparathyroidism
title_full Fahr Syndrome Secondary to Pseudohypoparathyroidism
title_fullStr Fahr Syndrome Secondary to Pseudohypoparathyroidism
title_full_unstemmed Fahr Syndrome Secondary to Pseudohypoparathyroidism
title_short Fahr Syndrome Secondary to Pseudohypoparathyroidism
title_sort fahr syndrome secondary to pseudohypoparathyroidism
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690847/
https://www.ncbi.nlm.nih.gov/pubmed/38045865
http://dx.doi.org/10.1210/jcemcr/luad147
work_keys_str_mv AT shusharonw fahrsyndromesecondarytopseudohypoparathyroidism
AT sharmasakshi fahrsyndromesecondarytopseudohypoparathyroidism
AT iqbalqasimz fahrsyndromesecondarytopseudohypoparathyroidism
AT romokarinag fahrsyndromesecondarytopseudohypoparathyroidism